Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Hepatocyte growth factor protects against isoniazid/rifampicin-induced oxidative liver damage.

Enriquez-Cortina C, Almonte-Becerril M, Clavijo-Cornejo D, Palestino-Domínguez M, Bello-Monroy O, Nuño N, López A, Bucio L, Souza V, Hernández-Pando R, Muñoz L, Gutiérrez-Ruiz MC, Gómez-Quiroz LE.

Toxicol Sci. 2013 Sep;135(1):26-36. doi: 10.1093/toxsci/kft134. Epub 2013 Jun 13.

PMID:
23764483
2.

The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.

Chen X, Xu J, Zhang C, Yu T, Wang H, Zhao M, Duan ZH, Zhang Y, Xu JM, Xu DX.

Eur J Pharmacol. 2011 May 20;659(1):53-60. doi: 10.1016/j.ejphar.2011.03.007. Epub 2011 Mar 22.

PMID:
21419764
3.

Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury.

Wang C, Fan RQ, Zhang YX, Nie H, Li K.

World J Gastroenterol. 2016 Nov 28;22(44):9775-9783.

4.

Hesperidin Alleviates Oxidative Stress and Upregulates the Multidrug Resistance Protein 2 in Isoniazid and Rifampicin-Induced Liver Injury in Rats.

Zhang G, Zhu J, Zhou Y, Wei Y, Xi L, Qin H, Rao Z, Han M, Ma Y, Wu X.

J Biochem Mol Toxicol. 2016 Jul;30(7):342-9. doi: 10.1002/jbt.21799. Epub 2016 Mar 28. No abstract available.

PMID:
27017938
5.

Protective effects of resveratrol on hepatotoxicity induced by isoniazid and rifampicin via SIRT1 modulation.

Nicoletti NF, Rodrigues-Junior V, Santos AA Jr, Leite CE, Dias AC, Batista EL Jr, Basso LA, Campos MM, Santos DS, Souto AA.

J Nat Prod. 2014 Oct 24;77(10):2190-5. doi: 10.1021/np5003143. Epub 2014 Oct 10.

PMID:
25302422
6.

Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.

Shih TY, Ho SC, Hsiong CH, Huang TY, Hu OY.

Curr Drug Metab. 2013 Jul;14(6):720-8.

PMID:
23701163
7.

Protective effects of metallothionein on isoniazid and rifampicin-induced hepatotoxicity in mice.

Lian Y, Zhao J, Xu P, Wang Y, Zhao J, Jia L, Fu Z, Jing L, Liu G, Peng S.

PLoS One. 2013 Aug 13;8(8):e72058. doi: 10.1371/journal.pone.0072058. eCollection 2013.

8.

The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity.

Guo YX, Xu XF, Zhang QZ, Li C, Deng Y, Jiang P, He LY, Peng WX.

Toxicol Mech Methods. 2015;25(5):382-7. doi: 10.3109/15376516.2015.1033074. Epub 2015 Apr 17.

PMID:
25886055
9.

Role of oxidative stress and nitric oxide in the protective effects of alpha-lipoic acid and aminoguanidine against isoniazid-rifampicin-induced hepatotoxicity in rats.

Saad EI, El-Gowilly SM, Sherhaa MO, Bistawroos AE.

Food Chem Toxicol. 2010 Jul;48(7):1869-75. doi: 10.1016/j.fct.2010.04.026. Epub 2010 Apr 22.

PMID:
20417245
10.

Protective effect of methanolic extract of Annona squamosa Linn in isoniazid-rifampicin induced hepatotoxicity in rats.

Thattakudian Sheik Uduman MS, Sundarapandian R, Muthumanikkam A, Kalimuthu G, Parameswari S A, Vasanthi Srinivas TR, Karunakaran G.

Pak J Pharm Sci. 2011 Apr;24(2):129-34.

PMID:
21454160
11.

Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats.

Santhosh S, Sini TK, Anandan R, Mathew PT.

Eur J Pharmacol. 2007 Oct 15;572(1):69-73. Epub 2007 Jun 13.

PMID:
17612523
12.

Effect of cimetidine on hepatotoxicity induced by isoniazid-rifampicin combination in rabbits.

Kalra BS, Aggarwal S, Khurana N, Gupta U.

Indian J Gastroenterol. 2007 Jan-Feb;26(1):18-21.

PMID:
17401229
13.

Evaluation of antihepatotoxic potential of Solanum xanthocarpum fruit extract against antitubercular drugs induced hepatopathy in experimental rodents.

Hussain T, Gupta RK, K S, Khan MS, Hussain MD, Arif MD, Hussain A, Faiyazuddin MD, Rao CV.

Asian Pac J Trop Biomed. 2012 Jun;2(6):454-60. doi: 10.1016/S2221-1691(12)60075-6.

14.

Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture.

Shen C, Cheng X, Li D, Meng Q.

Cell Biol Toxicol. 2009 Jun;25(3):265-74. doi: 10.1007/s10565-008-9076-8. Epub 2008 May 22.

PMID:
18496758
15.

Isoniazid- and rifampicin-induced oxidative hepatic injury--protection by N-acetylcysteine.

Attri S, Rana SV, Vaiphei K, Sodhi CP, Katyal R, Goel RC, Nain CK, Singh K.

Hum Exp Toxicol. 2000 Sep;19(9):517-22.

PMID:
11204554
16.

Monoammonium glycyrrhizinate protects rifampicin- and isoniazid-induced hepatotoxicity via regulating the expression of transporter Mrp2, Ntcp, and Oatp1a4 in liver.

Zhou L, Song Y, Zhao J, Qin H, Zhang G, Zhou Y, Wu X.

Pharm Biol. 2016;54(6):931-7. doi: 10.3109/13880209.2015.1070878. Epub 2016 Mar 17.

PMID:
26987268
17.

Hepatoprotective effects of Yulangsan polysaccharide against isoniazid and rifampicin-induced liver injury in mice.

Dong Y, Huang J, Lin X, Zhang S, Jiao Y, Liang T, Chen Z, Huang R.

J Ethnopharmacol. 2014 Feb 27;152(1):201-6. doi: 10.1016/j.jep.2014.01.001. Epub 2014 Jan 8.

PMID:
24412379
18.

Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice.

Chowdhury A, Santra A, Bhattacharjee K, Ghatak S, Saha DR, Dhali GK.

J Hepatol. 2006 Jul;45(1):117-26. Epub 2006 Feb 17.

PMID:
16545483
19.

Study of oxidative-stress in isoniazid-rifampicin induced hepatic injury in young rats.

Sodhi CP, Rana SV, Mehta SK, Vaiphei K, Attari S, Mehta S.

Drug Chem Toxicol. 1997 Aug;20(3):255-69.

PMID:
9292280
20.

Protective effects of the bioactive natural product N-trans-Caffeoyldopamine on hepatotoxicity induced by isoniazid and rifampicin.

Wu ZR, Bai ZT, Sun Y, Chen P, Yang ZG, Zhi DJ, Li Y, Wang X, Du JJ, Yang R, Cui P, Zhang Y, Li HY.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5424-6. doi: 10.1016/j.bmcl.2015.09.003. Epub 2015 Sep 5.

PMID:
26410075

Supplemental Content

Support Center